Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchAzithromycinAzithromycin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Association of prescribed medications with the risk of COVID-19 infection and severity among adults in South Korea

Huh et al., International Journal of Infectious Diseases, doi:10.1016/j.ijid.2020.12.041
Dec 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Progression -54% Improvement Relative Risk Case 42% Azithromycin for COVID-19  Huh et al.  Prophylaxis Is prophylaxis with azithromycin beneficial for COVID-19? Retrospective 44,046 patients in South Korea Higher progression (p=0.33) and fewer cases (p=0.1), not sig. c19early.org Huh et al., Int. J. Infectious Diseases, Dec 2020 Favorsazithromycin Favorscontrol 0 0.5 1 1.5 2+
Retrospective database analysis showing no significant differences with azithromycin use.
Study covers camostat, metformin, and HCQ.
risk of progression, 53.6% higher, RR 1.54, p = 0.33, treatment 3 of 6 (50.0%), control 875 of 2,799 (31.3%), adjusted per study, odds ratio converted to relative risk, multivariable.
risk of case, 42.0% lower, OR 0.58, p = 0.10, treatment 11 of 7,341 (0.1%) cases, 103 of 36,705 (0.3%) controls, NNT 14, adjusted per study, case control OR, multivariable.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Huh et al., 19 Dec 2020, retrospective, database analysis, South Korea, peer-reviewed, 8 authors.
This PaperAzithromycinAll
{ 'indexed': {'date-parts': [[2024, 3, 24]], 'date-time': '2024-03-24T07:32:49Z', 'timestamp': 1711265569489}, 'reference-count': 42, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2021, 3, 1]], 'date-time': '2021-03-01T00:00:00Z', 'timestamp': 1614556800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2020, 12, 15]], 'date-time': '2020-12-15T00:00:00Z', 'timestamp': 1607990400000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by-nc-nd/4.0/'}], 'funder': [ { 'DOI': '10.13039/501100006107', 'name': 'Gil Medical Center, Gachon University', 'doi-asserted-by': 'publisher'}], 'content-domain': { 'domain': [ 'ijidonline.com', 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.fr', 'clinicalkey.com.au', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2021, 3]]}, 'DOI': '10.1016/j.ijid.2020.12.041', 'type': 'journal-article', 'created': { 'date-parts': [[2020, 12, 19]], 'date-time': '2020-12-19T16:58:18Z', 'timestamp': 1608397098000}, 'page': '7-14', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 12, 'title': 'Association of prescribed medications with the risk of COVID-19 infection and severity among ' 'adults in South Korea', 'prefix': '10.1016', 'volume': '104', 'author': [ {'given': 'Kyungmin', 'family': 'Huh', 'sequence': 'first', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-7164-2770', 'authenticated-orcid': False, 'given': 'Wonjun', 'family': 'Ji', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-9428-0258', 'authenticated-orcid': False, 'given': 'Minsun', 'family': 'Kang', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-1855-9649', 'authenticated-orcid': False, 'given': 'Jinwook', 'family': 'Hong', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gi Hwan', 'family': 'Bae', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-4507-4877', 'authenticated-orcid': False, 'given': 'Rugyeom', 'family': 'Lee', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-0692-6299', 'authenticated-orcid': False, 'given': 'Yewon', 'family': 'Na', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-4856-3668', 'authenticated-orcid': False, 'given': 'Jaehun', 'family': 'Jung', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.ijid.2020.12.041_bib0005', 'doi-asserted-by': 'crossref', 'DOI': '10.1177/2047487320919233', 'article-title': 'Amiodarone as a possible therapy for coronavirus infection', 'author': 'Aimo', 'year': '2020', 'journal-title': 'Eur J Prev Cardiol'}, { 'key': '10.1016/j.ijid.2020.12.041_bib0010', 'series-title': 'HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in ' 'COVID-19', 'author': 'American College of Cardiology', 'year': '2020'}, { 'issue': '19', 'key': '10.1016/j.ijid.2020.12.041_bib0015', 'doi-asserted-by': 'crossref', 'first-page': '1813', 'DOI': '10.1056/NEJMoa2007764', 'article-title': 'Remdesivir for the treatment of covid-19 - final report', 'volume': '383', 'author': 'Beigel', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.ijid.2020.12.041_bib0020', 'doi-asserted-by': 'crossref', 'first-page': '517', 'DOI': '10.1056/NEJMoa2016638', 'article-title': 'A randomized trial of hydroxychloroquine as postexposure prophylaxis ' 'for covid-19', 'volume': '383', 'author': 'Boulware', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'issue': '6', 'key': '10.1016/j.ijid.2020.12.041_bib0025', 'doi-asserted-by': 'crossref', 'first-page': '606', 'DOI': '10.1016/j.jinf.2013.09.029', 'article-title': 'Broad-spectrum antivirals for the emerging Middle East respiratory ' 'syndrome coronavirus', 'volume': '67', 'author': 'Chan', 'year': '2013', 'journal-title': 'J Infect'}, { 'issue': '5', 'key': '10.1016/j.ijid.2020.12.041_bib0030', 'doi-asserted-by': 'crossref', 'first-page': '373', 'DOI': '10.1016/0021-9681(87)90171-8', 'article-title': 'A new method of classifying prognostic comorbidity in longitudinal ' 'studies: development and validation', 'volume': '40', 'author': 'Charlson', 'year': '1987', 'journal-title': 'J Chronic Dis'}, { 'key': '10.1016/j.ijid.2020.12.041_bib0035', 'doi-asserted-by': 'crossref', 'first-page': '9', 'DOI': '10.1016/j.antiviral.2014.12.011', 'article-title': 'Thiopurine analogs and mycophenolic acid synergistically inhibit the ' 'papain-like protease of Middle East respiratory syndrome coronavirus', 'volume': '115', 'author': 'Cheng', 'year': '2015', 'journal-title': 'Antiviral Res'}, { 'issue': '5', 'key': '10.1016/j.ijid.2020.12.041_bib0040', 'doi-asserted-by': 'crossref', 'first-page': '105938', 'DOI': '10.1016/j.ijantimicag.2020.105938', 'article-title': 'New insights on the antiviral effects of chloroquine against ' 'coronavirus: what to expect for COVID- 19?', 'volume': '55', 'author': 'Devaux', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'issue': '20', 'key': '10.1016/j.ijid.2020.12.041_bib0045', 'doi-asserted-by': 'crossref', 'first-page': '2605', 'DOI': '10.1161/CIRCULATIONAHA.104.510461', 'article-title': 'Effect of angiotensin-converting enzyme inhibition and angiotensin II ' 'receptor blockers on cardiac angiotensin-converting enzyme 2', 'volume': '111', 'author': 'Ferrario', 'year': '2005', 'journal-title': 'Circulation'}, { 'issue': '6', 'key': '10.1016/j.ijid.2020.12.041_bib0050', 'doi-asserted-by': 'crossref', 'first-page': 'F1297', 'DOI': '10.1152/ajprenal.00110.2010', 'article-title': 'The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function', 'volume': '298', 'author': 'Ferrario', 'year': '2010', 'journal-title': 'Am J Physiol Renal Physiol'}, { 'issue': '1', 'key': '10.1016/j.ijid.2020.12.041_bib0055', 'doi-asserted-by': 'crossref', 'first-page': '72', 'DOI': '10.5582/bst.2020.01047', 'article-title': 'Breakthrough: chloroquine phosphate has shown apparent efficacy in ' 'treatment of COVID-19 associated pneumonia in clinical studies', 'volume': '14', 'author': 'Gao', 'year': '2020', 'journal-title': 'Biosci Trends'}, { 'key': '10.1016/j.ijid.2020.12.041_bib0060', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105949', 'article-title': 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results ' 'of an open-label non-randomized clinical trial', 'author': 'Gautret', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'issue': '9', 'key': '10.1016/j.ijid.2020.12.041_bib0065', 'doi-asserted-by': 'crossref', 'first-page': '4122', 'DOI': '10.1128/JVI.02232-10', 'article-title': 'Evidence that TMPRSS2 activates the severe acute respiratory syndrome ' 'coronavirus spike protein for membrane fusion and reduces viral control ' 'by the humoral immune response', 'volume': '85', 'author': 'Glowacka', 'year': '2011', 'journal-title': 'J Virol'}, { 'issue': '1', 'key': '10.1016/j.ijid.2020.12.041_bib0070', 'doi-asserted-by': 'crossref', 'first-page': '19840', 'DOI': '10.1038/srep19840', 'article-title': 'Angiotensin-converting enzyme 2 inhibits lung injury induced by ' 'respiratory syncytial virus', 'volume': '6', 'author': 'Gu', 'year': '2016', 'journal-title': 'Sci Rep'}, { 'issue': '5', 'key': '10.1016/j.ijid.2020.12.041_bib0075', 'doi-asserted-by': 'crossref', 'first-page': '1023', 'DOI': '10.1007/s00705-004-0461-1', 'article-title': 'Susceptibility of different eukaryotic cell lines to SARS-coronavirus', 'volume': '150', 'author': 'Hattermann', 'year': '2005', 'journal-title': 'Arch Virol'}, { 'issue': '2', 'key': '10.1016/j.ijid.2020.12.041_bib0080', 'doi-asserted-by': 'crossref', 'first-page': '271', 'DOI': '10.1016/j.cell.2020.02.052', 'article-title': 'SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a ' 'clinically proven protease inhibitor', 'volume': '181', 'author': 'Hoffmann', 'year': '2020', 'journal-title': 'Cell'}, { 'issue': '21', 'key': '10.1016/j.ijid.2020.12.041_bib0085', 'doi-asserted-by': 'crossref', 'first-page': '2030', 'DOI': '10.1056/NEJMoa2022926', 'article-title': 'Effect of hydroxychloroquine in hospitalized patients with covid-19', 'volume': '383', 'author': 'Horby', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'issue': '4', 'key': '10.1016/j.ijid.2020.12.041_bib0090', 'doi-asserted-by': 'crossref', 'first-page': '469', 'DOI': '10.1111/joim.13119', 'article-title': 'Older age and comorbidity are independent mortality predictors in a ' 'large cohort of 1305 COVID-19 patients in Michigan, United States', 'volume': '288', 'author': 'Imam', 'year': '2020', 'journal-title': 'J Intern Med'}, { 'issue': '2', 'key': '10.1016/j.ijid.2020.12.041_bib0095', 'doi-asserted-by': 'crossref', 'first-page': '1088', 'DOI': '10.1128/AAC.03659-14', 'article-title': 'Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation ' 'for Middle East respiratory syndrome coronavirus infection as ' 'identified by temporal kinome analysis', 'volume': '59', 'author': 'Kindrachuk', 'year': '2015', 'journal-title': 'Antimicrob Agents Chemother'}, { 'key': '10.1016/j.ijid.2020.12.041_bib0100', 'series-title': 'COVID-19 Response Guidelines (Edition 8-1)', 'author': 'Korea Centers for Disease Control and Prevention', 'year': '2020'}, { 'issue': '8', 'key': '10.1016/j.ijid.2020.12.041_bib0105', 'doi-asserted-by': 'crossref', 'first-page': '875', 'DOI': '10.1038/nm1267', 'article-title': 'A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS ' 'coronavirus-induced lung injury', 'volume': '11', 'author': 'Kuba', 'year': '2005', 'journal-title': 'Nat Med'}, { 'issue': '6965', 'key': '10.1016/j.ijid.2020.12.041_bib0110', 'doi-asserted-by': 'crossref', 'first-page': '450', 'DOI': '10.1038/nature02145', 'article-title': 'Angiotensin-converting enzyme 2 is a functional receptor for the SARS ' 'coronavirus', 'volume': '426', 'author': 'Li', 'year': '2003', 'journal-title': 'Nature'}, { 'key': '10.1016/j.ijid.2020.12.041_bib0115', 'doi-asserted-by': 'crossref', 'first-page': 'm1185', 'DOI': '10.1136/bmj.m1185', 'article-title': 'Non-steroidal anti-inflammatory drugs and covid-19', 'volume': '368', 'author': 'Little', 'year': '2020', 'journal-title': 'BMJ'}, { 'issue': '7', 'key': '10.1016/j.ijid.2020.12.041_bib0120', 'doi-asserted-by': 'crossref', 'first-page': '317', 'DOI': '10.1021/acsinfecdis.5b00030', 'article-title': 'Evaluation of ebola virus inhibitors for drug repurposing', 'volume': '1', 'author': 'Madrid', 'year': '2015', 'journal-title': 'ACS Infect Dis'}, { 'issue': '1', 'key': '10.1016/j.ijid.2020.12.041_bib0125', 'first-page': '114', 'article-title': 'Outcomes of hydroxychloroquine usage in United States veterans ' 'hospitalized with Covid-19', 'volume': '1', 'author': 'Magagnoli', 'year': '2020', 'journal-title': 'Med (N Y)'}, { 'key': '10.1016/j.ijid.2020.12.041_bib0130', 'doi-asserted-by': 'crossref', 'first-page': '2431', 'DOI': '10.1056/NEJMoa2006923', 'article-title': 'Renin-angiotensin-aldosterone system blockers and the risk of Covid-19', 'volume': '382', 'author': 'Mancia', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'issue': '24', 'key': '10.1016/j.ijid.2020.12.041_bib0135', 'doi-asserted-by': 'crossref', 'first-page': '12658', 'DOI': '10.1128/JVI.01542-10', 'article-title': 'Efficient activation of the severe acute respiratory syndrome ' 'coronavirus spike protein by the transmembrane protease TMPRSS2', 'volume': '84', 'author': 'Matsuyama', 'year': '2010', 'journal-title': 'J Virol'}, { 'issue': '4', 'key': '10.1016/j.ijid.2020.12.041_bib0140', 'doi-asserted-by': 'crossref', 'first-page': '384', 'DOI': '10.1016/j.medmal.2020.03.006', 'article-title': 'No evidence of rapid antiviral clearance or clinical benefit with the ' 'combination of hydroxychloroquine and azithromycin in patients with ' 'severe COVID-19 infection', 'volume': '50', 'author': 'Molina', 'year': '2020', 'journal-title': 'Med Mal Infect'}, { 'issue': '6', 'key': '10.1016/j.ijid.2020.12.041_bib0145', 'doi-asserted-by': 'crossref', 'first-page': '3846', 'DOI': '10.1128/JVI.79.6.3846-3850.2005', 'article-title': 'Exogenous ACE2 expression allows refractory cell lines to support ' 'severe acute respiratory syndrome coronavirus replication', 'volume': '79', 'author': 'Mossel', 'year': '2005', 'journal-title': 'J Virol'}, { 'issue': '18', 'key': '10.1016/j.ijid.2020.12.041_bib0150', 'first-page': '1775', 'article-title': 'Case-fatality rate and characteristics of patients dying in relation to ' 'COVID-19 in Italy', 'volume': '323', 'author': 'Onder', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.ijid.2020.12.041_bib0155', 'article-title': 'Repurposed antiviral drugs for covid-19 - interim WHO solidarity trial ' 'results', 'author': 'Pan', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'issue': '50', 'key': '10.1016/j.ijid.2020.12.041_bib0160', 'doi-asserted-by': 'crossref', 'first-page': '14408', 'DOI': '10.1073/pnas.1618029113', 'article-title': 'Zika virus cell tropism in the developing human brain and inhibition by ' 'azithromycin', 'volume': '113', 'author': 'Retallack', 'year': '2016', 'journal-title': 'Proc Natl Acad Sci U S A'}, { 'key': '10.1016/j.ijid.2020.12.041_bib0165', 'doi-asserted-by': 'crossref', 'first-page': '2441', 'DOI': '10.1056/NEJMoa2008975', 'article-title': 'Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19', 'volume': '382', 'author': 'Reynolds', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'issue': '20', 'key': '10.1016/j.ijid.2020.12.041_bib0170', 'doi-asserted-by': 'crossref', 'first-page': '2052', 'DOI': '10.1001/jama.2020.6775', 'article-title': 'Presenting characteristics, comorbidities, and outcomes among 5700 ' 'patients hospitalized with COVID-19 in the New York City area', 'volume': '323', 'author': 'Richardson', 'year': '2020', 'journal-title': 'JAMA'}, { 'issue': '24', 'key': '10.1016/j.ijid.2020.12.041_bib0175', 'doi-asserted-by': 'crossref', 'first-page': '2493', 'DOI': '10.1001/jama.2020.8630', 'article-title': 'Association of treatment with hydroxychloroquine or azithromycin with ' 'in-hospital mortality in patients with COVID-19 in New York State', 'volume': '323', 'author': 'Rosenberg', 'year': '2020', 'journal-title': 'JAMA'}, { 'issue': '18', 'key': '10.1016/j.ijid.2020.12.041_bib0180', 'first-page': '1824', 'article-title': 'Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a ' 'review', 'volume': '323', 'author': 'Sanders', 'year': '2020', 'journal-title': 'JAMA'}, { 'issue': '1', 'key': '10.1016/j.ijid.2020.12.041_bib0185', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1214/09-STS313', 'article-title': 'Matching methods for causal inference: a review and a look forward', 'volume': '25', 'author': 'Stuart', 'year': '2010', 'journal-title': 'Stat Sci'}, { 'issue': '8', 'key': '10.1016/j.ijid.2020.12.041_bib0190', 'doi-asserted-by': 'crossref', 'first-page': '573', 'DOI': '10.7326/0003-4819-147-8-200710160-00010', 'article-title': 'The strengthening the reporting of observational studies in ' 'epidemiology (STROBE) statement: guidelines for reporting observational ' 'studies', 'volume': '147', 'author': 'von Elm', 'year': '2007', 'journal-title': 'Ann Intern Med'}, { 'key': '10.1016/j.ijid.2020.12.041_bib0195', 'doi-asserted-by': 'crossref', 'first-page': '269', 'DOI': '10.1038/s41422-020-0282-0', 'article-title': 'Remdesivir and chloroquine effectively inhibit the recently emerged ' 'novel coronavirus (2019-nCoV) in vitro', 'volume': '30', 'author': 'Wang', 'year': '2020', 'journal-title': 'Cell Res'}, { 'issue': '13', 'key': '10.1016/j.ijid.2020.12.041_bib0200', 'doi-asserted-by': 'crossref', 'first-page': '1239', 'DOI': '10.1001/jama.2020.2648', 'article-title': 'Characteristics of and important lessons from the coronavirus disease ' '2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases ' 'from the Chinese center for disease control and prevention', 'volume': '323', 'author': 'Wu', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.ijid.2020.12.041_bib0205', 'doi-asserted-by': 'crossref', 'first-page': '1671', 'DOI': '10.1161/CIRCRESAHA.120.317134', 'article-title': 'Association of inpatient use of angiotensin converting enzyme ' 'inhibitors and angiotensin II receptor blockers with mortality among ' 'patients with hypertension hospitalized with COVID-19', 'volume': '126', 'author': 'Zhang', 'year': '2020', 'journal-title': 'Circ Res'}, { 'key': '10.1016/j.ijid.2020.12.041_bib0210', 'doi-asserted-by': 'crossref', 'first-page': '302', 'DOI': '10.3389/fimmu.2018.00302', 'article-title': 'The immunomodulatory effects of macrolides-a systematic review of the ' 'underlying mechanisms', 'volume': '9', 'author': 'Zimmermann', 'year': '2018', 'journal-title': 'Front Immunol'}], 'container-title': 'International Journal of Infectious Diseases', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S1201971220325650?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S1201971220325650?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2021, 6, 12]], 'date-time': '2021-06-12T12:51:17Z', 'timestamp': 1623502277000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S1201971220325650'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 3]]}, 'references-count': 42, 'alternative-id': ['S1201971220325650'], 'URL': 'http://dx.doi.org/10.1016/j.ijid.2020.12.041', 'relation': {}, 'ISSN': ['1201-9712'], 'subject': ['Infectious Diseases', 'Microbiology (medical)', 'General Medicine'], 'container-title-short': 'International Journal of Infectious Diseases', 'published': {'date-parts': [[2021, 3]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Association of prescribed medications with the risk of COVID-19 infection and ' 'severity among adults in South Korea', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'International Journal of Infectious Diseases', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.ijid.2020.12.041', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2020 The Authors. Published by Elsevier Ltd on behalf of International ' 'Society for Infectious Diseases.', 'name': 'copyright', 'label': 'Copyright'}]}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit